Inflammation News and Research

RSS

Opuntia ficus indica, a type of prickly pear cactus reduces hangover symptoms

Everyone knows a sure the way to avoid a hangover is to abstain from drinking alcoholic beverages, or at least to drink without over-indulging.

29 Jun 2004

Eating eggs does not increase risk of cardiovascular disease

New research shows that egg cholesterol does not impact the harmful, most atherogenic, LDL-cholesterol particles in blood, according to a new study published in the June issue of Metabolism.

26 Jun 2004

Prescription pain medications may slow healing process in shoulder operations

A study of small laboratory animals suggests that prescription pain medications may delay healing in rotator cuff repair, a common shoulder operation, according to a new study by a team of doctors at the Hospital for Special Surgery.

26 Jun 2004

Mysterious disease that causes the body’s immune system to turn against itself

A mysterious disease that causes the body’s immune system to turn against itself also sends a warning signal to alert doctors of the onset of its worst symptoms, University of Florida physicians have found.

25 Jun 2004

Genetic variation that doubles the risk for rheumatoid arthritis

A team of researchers has discovered a genetic variation that doubles the risk for rheumatoid arthritis (RA).

24 Jun 2004

Can ginger increase metabolic rate and improve circulation in the hands and feet?

A pilot trial to discover whether ginger root can increase metabolic rate and improve circulation in the hands and feet is getting under way at The University of Reading.

23 Jun 2004

Exercise helps overweight men with erectile dysfunction

Erectile dysfunction is known to decrease the quality of life in men, and may affect as many as 30 million men in the United States alone, according to the new study. In a previous study, moderate-to-severe erectile dysfunction was reported by 12 percent of men below the age of 59; 22 percent of men aged 60 to 69 years; and 30 percent of 69 years and older.

22 Jun 2004

UK Rates of acute pancreatitis have doubled over the past 30 years

Rates of acute pancreatitis (inflammation of the pancreas) have doubled over the past 30 years, particularly among younger age groups, finds a study in this week's BMJ.

17 Jun 2004

Regular use of beta-agonist drugs for asthma could be endangering their patients

Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

17 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

New whole body positron emission tomography (PET) imaging allows scientists to watch as immune system respond to tumors or infection

Compared to the snapshot views of the immune system from tumor biopsies or blood assays, this whole body imaging allows scientists to track how the immune response changes, and the tumor or infection responds, throughout the different phases of immune response and over long periods of time.

15 Jun 2004

Inhibiting the expression of acidic mammalian chitinase (AMCase) may be effective in controlling asthma

A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid working as part of a team whose landmark study appears in the latest issue of the journal Science

15 Jun 2004

Significant vaccine advance for Parkinson’s disease therapy

Scientists at the University of Nebraska Medical Center in Omaha and Columbia University Medical Center in New York have discovered a new vaccine approach that successfully prevents the death of brain cells in a mouse model of Parkinson’s disease.

15 Jun 2004

New target for control of early-stage asthma

A new target for control of early-stage asthma has been identified by McGill University professor Qutayba Hamid, working as part of a team whose landmark study appears in the latest issue of the journal Science.

14 Jun 2004

Textured titanium medical implants may be better than smooth ones

Medical implants – from catheters that deliver long-term life support to joint replacements – may work better when their surfaces are on the rough side, new research suggests.

14 Jun 2004

Sirolimus-based therapy following early cyclosporine withdrawal improves transplanted kidney structure and function

Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.

11 Jun 2004

Pathogens have the ability to cause late-onset sporadic Alzheimer's disease

The possibility of an infectious etiology of chronic diseases, including Alzheimer’s disease, has long been debated and is difficult to prove.

11 Jun 2004

Crohn's disease and ulcerative colitis patients to rally in Washington

The Crohn's & Colitis Foundation of America (CCFA) is traveling to Washington, DC June 14th-15th to build support for legislation aimed at better understanding, preventing and curing Crohn's disease and ulcerative colitis.

11 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004